CD47 and diabetic retinopathy: Initially, to determine if the anti-IAP antibody was active in vivo and if early changes of diabetic retinopathy such as increased capillary permeability that were established could be reversed following anti-IAP antibody treatment, rats were made diabetic with streptozotocin.